Anti-N-methyl-D-aspartate receptor encephalitis: A patient with refractory illness after 25 months of intensive immunotherapy

JAMA Neurology

Volumn 70, Issue 12, 2013, Pages 1566-1568

  Thomas, Alissa ^a   Rauschkolb, Paula ^b   Gresa Arribas, Núria ^c   Schned, Alan ^a   Dalmau, Josep O ^c   Fadul, Camilo E ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b INTERMOUNTAIN MEDICAL CENTER   (United States)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FENTANYL CITRATE; HALOPERIDOL; IMMUNOGLOBULIN; LORAZEPAM; METHOTREXATE; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; PHENOBARBITAL; RECEPTOR ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

ADULT; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ANTIBODY TITER; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD ANALYSIS; BRAIN DISEASE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DEATH; DRUG MEGADOSE; FAMILY DECISION MAKING; FEMALE; HUMAN; HYPERKINESIA; LUMBAR PUNCTURE; MENTAL DISEASE; MINIMALLY CONSCIOUS STATE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVARIECTOMY; OVARY TERATOMA; PLASMAPHERESIS; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; SEIZURE; TREATMENT WITHDRAWAL;

EID: 84890352440     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.3205     Document Type: Article

References (9)

1. Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol. 2005;58(4):594-604.
2. Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61(1):25-36.
3. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157-165.
4. Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci. 2010;30(17):5866-5875.
5. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10(1):63-74.
6. Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y, Sangha N, Martinez-Lage M, Dalmau J. Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology. 2011;77(6):589-593.
7. Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain. 2010;133(pt 6):1655-1667.
8. Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology. 2011;77(2):179-189.
9. Titulaer MJ, Kayser MS, Dalmau J. Authors' reply. Lancet Neurol. 2013;12(5):425-426.